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ABSTRACT
Objective: The cause of post-menopausal 
osteoporosis is estrogen deficiency. The source 
and quality of estrogen changes during the post­
menopausal period. In this period the main 
estrogen in the circulation is estrone and is 
formed by the aromatization process of 
androgens peripherally. This process depends 
upon the body mass and age of the patients. 
Therefore the aim of this study was to determine 
the relationship between risk factors and 
reduction of bone density in Turkish post­
menopausal women.
Methods and Results:' A hundred post­
menopausal women were evaluated; their 
average age was 50.44 and their body mass 
index (BMI) were calculated (kg/m2). Their age, 
the duration of menopause and the 
presence/absence of smoking were taken into 
consideration. Bone mineral density assessment 
was done with Lunar DPX. The data obtained 
was evaluated by multiple regression analysis 
and x2 test.
Conclusion: We found that BMI varies directly 
and the duration of menopause indirectly with 
bone mineral density. The age of the patient on 
its own is barely related to bone mineral density 
whereas a history of smoking has no effect.
K e y  W o rd s : BMI and osteoporosis, Risk 
factors, Postmenopausal osteoporosis
IN TR O D U C T IO N
Osteoporosis is one of the major problems 
arising from estrogen deficiency in the 
postmenopausal period. Osteoporosis defines 
the reduction in bone density. In general, there 
are many factors leading to osteoporosis but the 
main cause of postmenopausal osteoporosis is 
the deficiency of estrogen. As follicular activity 
diminishes, 17-(3 estradiol, the basic estrogen in 
the circulation is replaced by estrone which is 
basically produced from androstenedione by the 
enzyme extraglandular aromatase. The activity 
of extraglandular aromatase depends on age and 
body weight and increases two fold in the 
perimenopausal period.
It is now well known that the change in the 
trabecular bone in postmenopausal women 
depends on estrogen deficiency. 75% or more of 
the reduction in bone density during the first 15 
years after menopause is caused by the 
deficiency of estrogen rather than aging.
Free androgens are converted to free estrogens 
in the skin and adipose tissues. The placement of 
the adipose cells in the body does not affect their 
activity. Women with central obesity possess a 
greater amount of androgens. Daily conversion 
of androstenedione to testosterone is less than 
1,5% in postmenopausal women, However, in 
obese women, this ratio and the level of sex 
steroids in the circulation is also affected by the 
sex hormone binding globulin (SHBG).
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Thirty percent 30% of the estrogens in the 
circulation are bound to albumin, 69% bound to 
SHBG and 1% are free. The level of SHBG in the 
circulation is indirectly correlated with the body 
weight and for this reason evident weight gain 
results in a decrease in the levels of SHBG, and 
an increase in the free sex steroid levels.
Estrogen deficiency also leads to a decrease in 
calcitonin levels secreted from the thyroid gland. 
Calcitonin reduces serum calcium levels by 
Inhibiting the osteoclastic activity which in turn 
means that it acts reversely to PTH's resorptive 
effect. Estrogens consequently inhibit the effects 
of PGE2 and interleukine which increase bone 
resorbtion. Estrogens stimulate the local 
production of transforming growth Factor-B 
(TGF-B) and insulin like growth factor-1 (IGF-1) 
which in turn stimulate bone formation. A 
significant increase in urinary calcium is detected 
in women who do not take estrogen replacement 
therapy.
The aim of this study was to determine the 
relationship between risk factors (Table I) and 
reduction of bone density in Turkish 
postmenopausal women.
MATERIALS AND METHODS
A hundred patients presenting to the Haydarpaşa 
Numune State Hospital Department of 
Gynecology and Obstetrics Menopause Out­
patient Clinic, between 1994-1996 were 
randomly selected.
We explored the relationship between age, 
duration of menopause, cigarette smoking and 
body mass index and the reduction of bone 
density. The data obtained was evaluated 
statistically by multiple regression analysis and 
the chi-square test.
Body-mass index (Quetelet Index) was 
measured by dividing the body weight to body 
surface (metric system).
Bone density was evaluated with Lunar DPX 
dualphoton absorptiometer using measurements 
of L2-L4 spine BMD (bone mineral density) and 
proximal femur BMD values.
Reference values for young adults and Z scores 
were based on the evaluation of fracture risks. 
According to this:
* BMD values under 80% in young adults 
(defines the bone density loss as more than 20%; 
Z score less than 2 SD) indicate that the person 
is in the osteoporosis risk group. This group is 
called "group 1" in our study.
* Values under 70% in young adults (this defines 
bone density loss as more than 30%; Z score 
less than 3 SD) indicate the absolute 
osteoporosis risk group. This group is called 
"group 2" in our study.
* Values under 60% for young adults (this defines 
bone density loss more than 40%; Z score less 
than 4 SD) show that severe osteoporosis is 
present, and even minimal trauma may cause 
fracture. This group is called "group 3".
Table I. The factors increasing the risk of postmenopausal 
osteoporosis
'high percentage of weight loss 
'alcohol abuse 
'high sodium intake 
"smoking
'high caffein intake
'high protein intake
'high phosphate intake
'Caucasian or Asian ethnic origin
'presence of family history
'low calcium intake
'early menopause or oopherectomy
'sedantary life style
'nulliparity
‘ secondary losses.
RESULTS
A total of 100 subjects were included In this 
study. The mean age, duration of menopause 
and BMI were 50.44 (range 29-67), 3.9 (range 1- 
18) and 26.47 (range 15-43), respectively. (Table
II) None of the subjects had an illness which 
could result in a decrease in bone density.
Ninteen percent of the population were smokers 
and 81% non-smokers.
Osteodensitometric investigations showed that 
45% of the selected patients had normal bone
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T a b le  II. Age, duration of menopause and BMI of the sampled 
population
MEAN MIN MAX STANDARD
ERROR
STANDARD
DEVIATION
AGE 50.44 29 67 0.574 5.74
DURATION OF
MENOPAUSE
(YEARS) 3.9 1 18 0.375 3.75
BMI 26.47 15 43 0.46 4.60
mineral density; 32% were in the risk group; 16% 
had osteoporosis and 7% had fracture risk with 
minimal trauma (Table III).
A borderline relationship was detected between 
bone mineral density and age by the one-way 
variance analysis (Table III).
A significant relationship was detected by one­
way variance analysis between duration of 
menopause and bone density (Table III).
A significant relationship was detected by one­
way variance analysis between BMI and bone 
density (Table III).
No relation was detected between cigarette 
smoking and bone mineral density (x2=1.333, 
p=0.72)
DISCUSSION
Studies concerning risk factors in osteoporosis 
and its prevention carried out by Tuppurainen et
al (1) for perimenopausal, and Biberoglu et al (2) 
for postmenopausal women showed that fracture 
incidence increases with age, and that 
menopause affects the fracture formation risk 
more intensively than 5 years of chronological 
ageing. Kroger et al's (3) study on 1600 
perimenopausal, Bauer (4) and McKnight et al's
(5) studies concerning postmenopausal women 
revealed that reduction in bone mineral density is 
well correlated with the duration of menopause 
rather than with chronologic age, and that BMI 
shows positive correlation with bone mineral 
density. Kleerekoper (6), Johnell (7) and Suzuki 
et al (8) demonstrated that the menopausal 
period is a clear risk factor for osteoporosis. In 
their study in 1993, Nelson et al (9) reached the 
result that high BMI is not a preventive factor for 
osteoporosis. Dawson et al (10) stated in their 
study that high body weight is related to much 
more mineralized bone structure, but that this 
effect is only available when body weight reaches 
110% of normal conditions; no concensus is 
present for the preventive effect of body weight; 
smoking increases the rate of bone loss and 
decreases bone mass.
However Kroger (3) and McKnight (5) showed in 
their study that smoking is not a risk factor for low 
bone mineral density; Bauer (7) defined in his 
study that smoking is an absolute risk factor 
causing bone density reduction.
In our study we found that bone density is 
negatively correlated with the duration of 
menopause but positively correlated with BMI 
(p<0.05). Bone mineral density is well protected 
in women with a high weight-to-height ratio and 
BMI and the risk of postmenopausal osteoposis
T a b le  III. Bone Mineral Density results of the sampled population, the relationship between bone mineral density and age, duration of 
menopause, and BMI
Bone Mineral 
Density
Percentage in the 
Sampled Population
Mean Age* Mean Menopause" 
Time (year)
BMI***
- Normal (no BMD loss) 45% 49.02 3 28
- Risk Group 32% 50.91 4 26
(BMD Loss more than 20%)
- Osteoporosis Group 16% 52.75 6 23
(BMD loss more than 30%)
- Fracture risk with minimal trauma 7% 52.14 7 21
(BMD loss more than 40%)
* F value = 2.12 p= 0.102 ** F value = 4.2993 p= 0.0068 *** F value = 3.433 p = 0.038
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is lower than those with a low weight-to-height 
ratio and BMI.
There is only a borderline relation between the 
patient's age and bone mineral density. The 
duration of the menopause ("the hypoestrogenic 
period") is more significant in reduction of bone 
mineral density than the age at which 
menopause begins.
We found no statistically significant relationship 
between smoking and osteoporosis (p>0.05). 
There are many studies showing the relationship 
between cigarette consumption and osteoporosis 
with different results and our findings are 
generally not compatible with the current 
literature. We came to the conclusion that, 
because the ratio of cigarette consumption in 
Turkey in women over the age of 40 is low, this 
naturally affects statistical data. Different results 
may be available if larger cohort studies are 
carried out.
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